[Urinary prostaglandin levels in patients with arterial hypertension with benign and malignant course].
With radioimmunoassay, daily urinary levels of prostaglandins E2 and F2 alpha (PGE2, FGF2 alpha were measured in 45 patients with hypertensive disease, 13 patients with chronic diffuse glomerulonephritis and 14 healthy persons. A progressive reduction in urinary PGE2 excretion was found to accompany the occurrence of labile arterial hypertension (AH), its stabilization, and development of malignant AH in patients with hypertensive disease or chronic diffuse glomerulonephritis. When labile AH developed, urinary PGF2 alpha excretion was increased, but when AH stabilized, its excretion became increased up to the baseline level. The specific features of malignant AH are significantly higher urinary PGF2 alpha and sharply greater PGF2 alpha/PGE2 coefficient. The identified abnormal metabolism of renal prostaglandins may contribute to the stabilization of blood pressure at a high level and to the development of malignant AH.
Runikhin
A Iu
AIu
Nekrasova
A A
AA
Levitskaia
Iu V
IuV
Arabidze
G G
GG
D002940:Circadian Rhythm; D015237:Dinoprost / Q000652:urine*; D015232:Dinoprostone / Q000652:urine*; D005921:Glomerulonephritis / Q000150:complications / Q000652:urine; D006801:Humans; D006973:Hypertension / Q000209:etiology / Q000652:urine*; D006974:Hypertension, Malignant / Q000209:etiology / Q000652:urine*; D012016:Reference Values
D015237:Dinoprost; D015232:Dinoprostone
Soderzhanie prostaglandinov v moche u bol'nykh arterial'noĭ gipertonieĭ dobrokachestvennogo i zlokachestvennogo techeniia.